Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Brooklyn ImmunoTherapeutics, Inc. | brhc10023524_8k.htm |
Exhibit 16.1
April 23, 2021
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
We have read Item 4.01 of Brooklyn ImmunoTherapeutics, Inc.’s Form 8-K dated April 21, 2021. We agree with the statements made in response to that Item insofar as they relate to our Firm.
Very truly yours,
/s/ BAKER TILLY US, LLP